Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Performance of Indexed and Nonindexed Estimated GFR

    Research output: Contribution to journalLetterResearchpeer-review

  2. Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder

    Research output: Contribution to journalEditorialResearchpeer-review

  3. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup

    Research output: Contribution to journalReviewResearchpeer-review

  3. Adverse effects from selected antidotes commonly used in poisonings

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Scandinavia

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

View graph of relations

Toxicity from gabapentin and pregabalin overdose is commonly encountered. Treatment is supportive, and the use of extracorporeal treatments (ECTRs) is controversial. The EXTRIP workgroup conducted systematic reviews of the literature and summarized findings following published methods. Thirty-three articles (30 patient reports and 3 pharmacokinetic studies) met the inclusion criteria. High gabapentinoid extracorporeal clearance (>150mL/min) and short elimination half-life (<5 hours) were reported with hemodialysis. The workgroup assessed gabapentin and pregabalin as "dialyzable" for patients with decreased kidney function (quality of the evidence grade as A and B, respectively). Limited clinical data were available (24 patients with gabapentin toxicity and 7 with pregabalin toxicity received ECTR). Severe toxicity, mortality, and sequelae were rare in cases receiving ECTR and in historical controls receiving standard care alone. No clear clinical benefit from ECTR could be identified although major knowledge gaps were acknowledged, as well as costs and harms of ECTR. The EXTRIP workgroup suggests against performing ECTR in addition to standard care rather than standard care alone (weak recommendation, very low quality of evidence) for gabapentinoid poisoning in patients with normal kidney function. If decreased kidney function and coma requiring mechanical ventilation are present, the workgroup suggests performing ECTR in addition to standard care (weak recommendation, very low quality of evidence).

Original languageEnglish
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
Volume79
Issue number1
Pages (from-to)88-104
Number of pages17
ISSN0272-6386
DOIs
Publication statusPublished - Jan 2022

Bibliographical note

Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

ID: 70643863